Public list Neuroscience Startups (947)
:Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result,...Show all
Company (Alive / Active)
Phone:
1800 Bering Drive
#430
Houston, 77057
Texas, United States
Total Funding | Date of Last Funding | |
---|---|---|
Alzeca Biosciences | $11M | Aug 17, 2017 |
Satoris | $5.2M | Nov 22, 2010 |
Avid Radiopharmaceuticals | $68.4M | Nov 8, 2010 |
See all 17 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Name | Firm |
---|---|
Login to see details | Chemwerth |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Lipid-based nanoparticles | Oct 30, 2017 | Nov 13, 2018 | Patent |
Functionalized liposomes for imaging misfolded proteins | Jan 24, 2020 | Application |